Journal article
Increase in Ca2 + current by sustained cAMP levels enhances proliferation rate in GH3 cells
- Abstract:
-
Aims: Ca2 + and cAMP are important intracellular modulators. In order to generate intracellular signals with various amplitudes, as well as different temporal and spatial properties, a tightly and precise control of these modulators in intracellular compartments is necessary. The aim of this study was to evaluate the effects of elevated and sustained cAMP levels on voltage-dependent Ca2 + currents and proliferation in pituitary tumor GH3 cells.
Main methods: Effect of long-term exposure to forskolin and dibutyryl-cyclic AMP (dbcAMP) on Ca2 + current density and cell proliferation rate were determined by using the whole-cell patch-clamp technique and real time cell monitoring system. The cAMP levels were assayed, after exposing transfected GH3 cells with the EPAC-1 cAMP sensor to forskolin and dbcAMP, by FRET analysis.
Key findings: Sustained forskolin treatment (24 and 48 h) induced a significant increase in total Ca2 + current density in GH3 cells. Accordingly, dibutyryl-cAMP incubation (dbcAMP) also elicited increase in Ca2 + current density. However, the maximum effect of dbcAMP occurred only after 72 h incubation, whereas forskolin showed maximal effect at 48 h. FRET-experiments confirmed that the time-course to elevate intracellular cAMP was distinct between forskolin and dbcAMP. Mibefradil inhibited the fast inactivating current component selectively, indicating the recruitment of T-type Ca2 + channels. A significant increase on cell proliferation rate, which could be related to the elevated and sustained intracellular levels of cAMP was observed.
Significance: We conclude that maintaining high levels of intracellular cAMP will cause an increase in Ca2 + current density and this phenomenon impacts proliferation rate in GH3 cells.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 569.0KB, Terms of use)
-
- Publisher copy:
- 10.1016/j.lfs.2017.11.040
Authors
- Publisher:
- Elsevier
- Journal:
- Life Sciences More from this journal
- Volume:
- 192
- Pages:
- 144-150
- Publication date:
- 2017-11-26
- Acceptance date:
- 2017-11-24
- DOI:
- EISSN:
-
1879-0631
- ISSN:
-
0024-3205
- Pmid:
-
29183797
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:812992
- UUID:
-
uuid:dc5eeff6-adee-453b-a3af-8c9677bcd30f
- Local pid:
-
pubs:812992
- Source identifiers:
-
812992
- Deposit date:
-
2018-08-14
Terms of use
- Copyright holder:
- Elsevier
- Copyright date:
- 2017
- Notes:
- © 2017 Elsevier Inc. All rights reserved. This is the author accepted manuscript following peer review version of the article. The final version is available online from Elsevier at: 10.1016/j.lfs.2017.11.040
If you are the owner of this record, you can report an update to it here: Report update to this record